Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic significance of VHL, HIF1A, HIF2A, VEGFA and p53 expression in patients with clear‑cell renal cell carcinoma treated with sunitinib as first‑line treatment
Piotr Wierzbicki, Jakub Kłącz, Anna Kotulak‐Chrząszcz, et al.
International Journal of Oncology (2019)
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Hypoxia-Driven Immune Escape in the Tumor Microenvironment
Alyssa Vito, Nader El-Sayes, Karen L. Mossman
Cells (2020) Vol. 9, Iss. 4, pp. 992-992
Open Access | Times Cited: 204
Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies
Raefa Abou Khouzam, Klaudia Brodaczewska, Aleksandra Filipiak-Duliban, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 154
Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study
Toni K. Choueiri, David F. McDermott, Jaime R. Merchan, et al.
The Lancet Oncology (2023) Vol. 24, Iss. 5, pp. 553-562
Closed Access | Times Cited: 62
Obesity-Dependent Adipokine Chemerin Suppresses Fatty Acid Oxidation to Confer Ferroptosis Resistance
Sze Kiat Tan, Iqbal Mahmud, Flavia Fontanesi, et al.
Cancer Discovery (2021) Vol. 11, Iss. 8, pp. 2072-2093
Open Access | Times Cited: 74
Fatty Acid Oxidation Mediated by Malonyl-CoA Decarboxylase Represses Renal Cell Carcinoma Progression
Lijie Zhou, Yongbo Luo, Yuenan Liu, et al.
Cancer Research (2023) Vol. 83, Iss. 23, pp. 3920-3939
Open Access | Times Cited: 21
Biomarkers for Renal Cell Carcinoma Recurrence: State of the Art
Michele Marchioni, Juan Gómez Rivas, Anamaría Autrán, et al.
Current Urology Reports (2021) Vol. 22, Iss. 6
Open Access | Times Cited: 33
Selective HIF2A Inhibitors in the Management of Clear Cell Renal Cancer and Von Hippel–Lindau-Disease-Associated Tumors
Cristina Suárez, María Vieito, Augusto Valdivia, et al.
Medical Sciences (2023) Vol. 11, Iss. 3, pp. 46-46
Open Access | Times Cited: 14
Repurposing ketoconazole as an exosome directed adjunct to sunitinib in treating renal cell carcinoma
Jacob Greenberg, Hogyoung Kim, Ahmed A. Moustafa, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 31
FN1 and cancer‐associated fibroblasts markers influence immune microenvironment in clear cell renal cell carcinoma
Gayathri Ashok, Sudha Ramaiah
The Journal of Gene Medicine (2023) Vol. 25, Iss. 12
Closed Access | Times Cited: 13
Exosomes derived from mesenchymal stem cells curbs the progression of clear cell renal cell carcinoma through T-cell immune response
Daoyuan Li, Feifei Lin, Guoping Li, et al.
Cytotechnology (2021) Vol. 73, Iss. 4, pp. 593-604
Open Access | Times Cited: 26
Efficacy and Safety of Nivolumab Plus Ipilimumab for Metastatic Renal Cell Carcinoma in Patients 75 Years and Older: Multicenter Retrospective Study
Shimpei Yamashita, Shuzo Hamamoto, Junya Furukawa, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 474-474
Open Access
HIF1A, EPAS1, and VEGFA: angiogenesis and hypoxia-related gene expression in endometrium and endometrial epithelial tumors
Monika Englert-Golon, Małgorzata Tokłowicz, Aleksandra Żbikowska, et al.
Journal of Applied Genetics (2025)
Open Access
Manganese-Doped Nanoparticles with Hypoxia-Inducible Factor 2α Inhibitor That Elicit Innate Immune Responses against von Hippel–Lindau Protein-Deficient Tumors
Fang Yan, Feiyang Shen, Rui Huang, et al.
ACS Nano (2025)
Closed Access
Hsa-miR-21-5p and Hsa-miR-145-5p Expression: From Normal Tissue to Malignant Changes—Context-Dependent Correlation with Estrogen- and Hypoxia–Vascularization-Related Pathways Genes: A Pilot Study
Marian Gorecki, Aleksandra Żbikowska, Małgorzata Tokłowicz, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4461-4461
Open Access
<p>Mutational Characterization and Potential Prognostic Biomarkers of Chinese Patients with Esophageal Squamous Cell Carcinoma</p>
Nan Zhang, Junping Shi, Xiaoliang Shi, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 12797-12809
Open Access | Times Cited: 26
Expression levels of sonic hedgehog pathway genes and their targets are upregulated in early clear cell renal cell carcinoma
Anna Kotulak‐Chrząszcz, Agnieszka Rybarczyk, Jakub Kłącz, et al.
International Journal of Molecular Medicine (2022) Vol. 49, Iss. 5
Open Access | Times Cited: 15
The up‐regulation of NDRG1 by HIF counteracts the cancer‐promoting effect of HIF in VHL‐deficient clear cell renal cell carcinoma
Zhengyan Zhang, Shilong Zhang, Hui‐Ling Chen, et al.
Cell Proliferation (2020) Vol. 53, Iss. 7
Open Access | Times Cited: 19
Atractylenolide I inhibits angiogenesis and reverses sunitinib resistance in clear cell renal cell carcinoma through ATP6V0D2-mediated autophagic degradation of EPAS1/HIF2α
Qinyu Li, Kai Zeng, Qian Chen, et al.
Autophagy (2024), pp. 1-20
Open Access | Times Cited: 2
Advancements in the identification of EV derived mRNA biomarkers for liquid biopsy of clear cell renal cell carcinomas
Morgan D. Kuczler, Richard C. Zieren, Liang Dong, et al.
Urology (2021) Vol. 160, pp. 87-93
Open Access | Times Cited: 15
CD70-Targeted Micelles Enhance HIF2α siRNA Delivery and Inhibit Oncogenic Functions in Patient-Derived Clear Cell Renal Carcinoma Cells
Noah Trac, Hyun Seok Oh, Leila Izzy Jones, et al.
Molecules (2022) Vol. 27, Iss. 23, pp. 8457-8457
Open Access | Times Cited: 10
Potential therapeutic target secretogranin II might cooperate with hypoxia‐inducible factor 1α in sunitinib‐resistant renal cell carcinoma
Wataru Fukumoto, Hirofumi Yoshino, Shin‐ichi Horike, et al.
Cancer Science (2023) Vol. 114, Iss. 10, pp. 3946-3956
Open Access | Times Cited: 6
Clinicopathologic significance of the delta-like ligand 4, vascular endothelial growth factor, and hypoxia-inducible factor-2α in gallbladder cancer
Sujin Park, Junsik Kim, Woncheol Jang, et al.
Journal of Pathology and Translational Medicine (2023) Vol. 57, Iss. 2, pp. 113-122
Open Access | Times Cited: 5
The role of occlusion and micro-incontinence in the pathogenesis of penile lichen sclerosus: an observational study of pro-inflammatory cytokines’ gene expression
Mateusz Czajkowski, Piotr Wierzbicki, Anna Kotulak‐Chrząszcz, et al.
International Urology and Nephrology (2022) Vol. 54, Iss. 4, pp. 763-772
Open Access | Times Cited: 9
Differential Expression of HIF1A, EPAS1, and VEGF Genes in Benign and Malignant Ovarian Neoplasia
Monika Englert-Golon, Małgorzata Tokłowicz, Aleksandra Żbikowska, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4899-4899
Open Access | Times Cited: 7
Altered mRNA Expression of NFKB1 and NFKB2 Genes in Penile Lichen Sclerosus, Penile Cancer and Zoon Balanitis
Piotr Wierzbicki, Mateusz Czajkowski, Anna Kotulak‐Chrząszcz, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 24, pp. 7254-7254
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top